Three independent discounted-cash-flow-style models value NRC Health Common Stock every trading day. 0 of 3 currently price NRC above its market price.
| Free Cash Flow model | $16.31 |
| Excess Profit model | $14.81 |
| Residual Earnings model | $11.31 |
| Dividend Discount model | $11.67 |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +18.2% |
| Net debt / EBITDA | 3.5× |
| Gross margin | +61.9% |
| Revenue CAGR | -3.2% |
| Cash conversion | 2.3× |
| Dividend yield | +3.1% |
| Buyback yield | +5.6% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open NRC in StockKitty